ESR1 and Li-Fraumeni syndrome: Our observation that induced loss of p53 leads to expansion of ER+ ductal luminal cells is of particular interest, as in women with Li-Fraumeni Syndrome (that is, with TP53 germline mutation), the most prevalent invasive breast tumours developed in them are ER+ (ref. 50).